ArticlePolymers2025
Highly-Oriented Polylactic Acid Fiber Reinforced Polycaprolactone Composite Produced by Infused Fiber Mat Process for 3D Printed Tissue Engineering Technology.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Three-dimensional printed polycaprolactone (PCL) tissue engineering scaffolds have drawn increasing interest from the medical industry due to their excellent biocompatibility and biodegradability, yet PCL's poor mechanical performance has limited their applications. This study introduces a biocompatible and biodegradable polylactic acid (PLA) fiber reinforced PCL (PLA/PCL) composite as the filament for 3D printed scaffolds to significantly enhance their mechanical performance: Special-made PLA short fiber mat was infused with PCL matrix and rolled into PLA/PCL filaments through a "Vacuum Assisted Resin Infusion" (VARI) process. The investigation revealed that the PLA fibers are highly oriented along the printing direction when using this filament for 3D printing due to the unique microstructure formed during the VARI process. At the same PLA fiber content, the percentage increase in Young's modulus of the 3D printed strands using the filaments produced by the VARI process is 127.6% higher than the 3D printed strands using the filaments produced by the conventional melt blending process. The 3D printed tissue engineering scaffolds using the PLA/PCL composite filament with 11 wt% PLA fiber content also achieved an exceptional 84.2% and 143.3% increase in peak load and stiffness compared to the neat PCL counterpart.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.